Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: December 6, 2007

NaturalNano to Present at the 3rd Annual Axiom Capital Mgmt/Livingston Nanotech Conference

(Nanowerk News) NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) President and Chief Technology Officer Cathy Fleischer, Ph.D. will present at the Third Annual Axiom Capital Management/Livingston Nanotechnology Conference in New York City at 2:40 p.m. Eastern (or EST), Friday, Dec. 7, 2007. The conference will be held at the Marriott Financial Center.
Fleischer said, “This conference is an opportunity for us to present the groundbreaking work that NaturalNano is doing both in the lab and with our joint development partners. We are also looking forward to showcasing the multiple advantages our proprietary, turn key additive Pleximer™, brings to the marketplace in enabling manufacturers to create stronger, lighter and less expensive materials.”
NaturalNano (www.naturalnano.com) also said it will discuss its recent nanomaterial licensing deal with the Naval Research Laboratory (NRL), and will give an update on its overall efforts toward product commercialization.
About NaturalNano, Inc.
NaturalNano, Inc. is a materials science company focused on developing and commercializing advanced nanocomposites. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer™ polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. For more information, visit http://www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements:
This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
Source: NaturalNano